http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106608911-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-505 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-505 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-06 |
| filingDate | 2015-10-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2020-01-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2020-01-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-106608911-B |
| titleOfInvention | Disulfide bond modified EPO (erythropoietin) peptidomimetic derivative and preparation method and application thereof |
| abstract | The invention relates to an erythropoietin mimic peptide derivative with a long-acting erythropoiesis function. The invention also provides a preparation method of the erythropoietin mimic peptide derivative and application of the erythropoietin mimic peptide derivative in preparing a medicament for treating diseases characterized by deficiency of erythropoietin or deficiency or defect of erythrocyte groups. The erythropoietin mimetic peptide derivative provided by the invention is polypeptide shown by SEQ ID NO1, and the structural general formula is shown as formula I; wherein two cysteines of the polypeptide form a disulfide bond and the N-terminus is acetylated. SEQ ID NO 1: |
| priorityDate | 2015-10-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 62.